The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
about
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective studyMetabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesPatients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaMicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyMetabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma.Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cellsQuality of Life and Sexual Health in the Aging of PCa Survivors.Obesity, age, ethnicity, and clinical features of prostate cancer patients.Expression of RABEX-5 and its clinical significance in prostate cancer.Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.Metabolic syndrome in prostate cancer: impact on risk and outcomesSULF2 overexpression positively regulates tumorigenicity of human prostate cancer cellsMiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.Meta-analysis of metabolic syndrome and prostate cancer.Unhealthy diets: a common soil for the association of metabolic syndrome and cancer.Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.Effect of metabolic syndrome and its components on recurrence and survival in early-stage non-small cell lung cancer.Introduction: What to Eat When You Can't Eat.Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.Metabesity and urological cancers.Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease.Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases.
P2860
Q28596648-D466ADEA-27F6-41D0-AB52-45BB41392E27Q30234898-0B0EAB5F-4E81-466E-ABE2-C8B6DF619D28Q31152938-2C969732-E023-4C18-8E2C-F960BAC6BEE7Q35781093-0587DC70-E985-43E5-ACC0-65FFBB75514AQ36025254-D3A53939-86D7-4654-9699-676B611EE873Q36044730-C92B4700-B93E-49DA-A09B-C6CA1145E6B6Q36121181-3B554460-D0C5-48E4-8B48-5726666D5262Q37367755-A9EB0686-59B7-4F63-AEC1-A02CA8512A1CQ37405631-AF56D441-6B2B-462A-A91C-AE9FF9BB58F8Q37686901-B719869D-F1F4-4C08-A83D-833BD011372AQ37692208-EEFC7F85-ED8E-4327-85E0-674566C54148Q37718867-915A891C-C25B-4D10-9737-AE1E029239F0Q38540337-869E35E1-2266-4A3E-8569-0007F810C230Q38805127-6296EC2A-6255-4569-97B8-7602F65EB7CEQ38885517-AB1231BC-2930-412D-BA84-72F8EC3763B2Q38914799-2451CB95-AFCA-4DF2-ABD0-6766B97D70D3Q39145052-58DEDCBA-74C1-40AD-B034-2E6EF527C3DBQ39275825-F7BAC560-5C7E-4CB5-A3B8-414F97C7FBEAQ40376269-F27D34FF-FB89-4EBF-A46A-7E7E613CFCA8Q41139603-173FCDC3-7E5B-4DAA-8B54-721B12247790Q41725990-7B4A3EBC-767A-42F1-9653-3E3CC1B178E3Q42054690-D1A32B3C-57EF-47FC-907F-3A926EA100C6Q42821211-B014D3AE-4888-4B00-99FA-9A79E3DA25FEQ47107153-A3FE3ED2-6582-469C-9E9C-82730045591CQ47139943-1AC8FE8A-2E66-4650-821E-ABA79B0C5A2EQ51595786-6E78D9A9-FBA0-4814-ACCD-53F747E3407AQ53291460-25B788B5-EEC8-4C5D-AC03-4C2FD7F57544Q55492100-56B1FA80-9796-4899-9854-0E34BECAAF12
P2860
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The association between metabo ...... ity and biochemical recurrence
@ast
The association between metabo ...... ity and biochemical recurrence
@en
type
label
The association between metabo ...... ity and biochemical recurrence
@ast
The association between metabo ...... ity and biochemical recurrence
@en
prefLabel
The association between metabo ...... ity and biochemical recurrence
@ast
The association between metabo ...... ity and biochemical recurrence
@en
P2093
P2860
P31
P356
P1476
The association between metabo ...... ity and biochemical recurrence
@en
P2093
Guan-bin Li
Qing-hua Xia
Shao-bo Jiang
Xun-bo Jin
Yu-zhu Xiang
Zi-lian Cui
P2860
P2888
P356
10.1186/1756-9966-32-9
P5008
P577
2013-02-13T00:00:00Z
P5875
P6179
1008942699